Learn more about the GLP-1 medications that our doctors may prescribe. Due to supply shortages, physicians may prescribe patients semaglutide or tirzepatide blended with cyanocobalamin (vitamin B-12) and compounded by a trusted pharmacy partner.


Semaglutide is a GLP-1 receptor agonist that is FDA approved for weight loss under the brand name Wegovy and for type 2 diabetes under the brand name Ozempic. Semaglutide is taken as a weekly subcutaneous injection.


Tirzepatide is a GLP-1 receptor agonist and GIP (glucose-dependent insulinotropic polypeptide) receptor. It is commonly known by the brand names Mounjaro for type 2 diabetes and Zepbound for weight loss.